Daily Balance Emulsion Base

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Cosmetic washes, gels, and emulsions use glycerin in a polyol-humectant role; the listed level is for formulation development.

3. Typical use levels (formulation guide)

• For gels and serums, use 3–8% in this reference.
• For creams, use 2–5%.
• The level shown for rinse-off is 2–4%.

Add Glycerin to the water phase; no separate melt step is needed.

4. Regulatory sources & global compliance

• The CosIng record for Glycerin, where listed, is informational rather than product-specific authorization.
• Regulation (EC) No 1223/2009 requires an assessment addressing the safety of the finished product that contains Glycerin rather than for an ingredient name alone.
• Establish grade-specific details for Glycerin from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; the note establishes neither drug approval nor OTC-monograph status with patch response and finished-product stability still to be verified.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; where oxidation is a concern, evaluate airless or pump packaging; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Glycerin emphasizes humectant function.

• The cosmetic listing cannot substantiate therapeutic effects, curative outcomes, or unsupported certification statements.
• The available details for Glycerin does not demonstrate whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

As a hydrocarbon emollient, squalane offers stability; the grade in this guide is plant-derived rather than mineral oil.

3. Typical use levels (formulation guide)

• 2–6% is listed for gel-creams.
• Dry oils may use the guide range 10–30% as a formulation guide.
• Balms may use the guide range 5–15% as a formulation guide.

The guide places Squalane in the oil phase and calls for no high-shear wax processing.

4. Regulatory sources & global compliance

• Use CosIng's information on Squalane as a reference, then verify the specific grade and intended use under market rules.
• EU market placement under Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Squalane in the final product context.
• Compare the received Squalane material with its supplier specification and review destination-market filing needs.

5. Safety & risk assessment

This level is a cosmetic-formulation guide; this reference is not approval for drug use or OTC marketing so patch response and stability should be checked on the finished product.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; if the formula is oxidation-sensitive, an airless or pump format may be considered; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The formulation note describes Squalane as part of a cosmetic direction focused on a light-emollient role.

• This product entry cannot substantiate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The ingredient note for Squalane cannot establish whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI & CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Role in the formula

Caprylic/capric triglyceride is used as a light oil in lotions, balms, and cleansing oils.

3. Typical use levels (formulation guide)

• The formulation record indicates 3–8% for lotions in this reference.
• For cleansing oils and balms, the recorded level is 20–60% as a formulation guide.

Incorporate Caprylic/Capric Triglyceride in the oil phase.

4. Regulatory sources & global compliance

• The CosIng record for Caprylic/Capric Triglyceride, where listed, is informational rather than product-specific authorization.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires the complete cosmetic containing Caprylic/Capric Triglyceride to receive its own safety assessment as a finished-product assessment.
• Establish grade-specific details for Caprylic/Capric Triglyceride from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it makes no claim of drug or OTC authorization and the final formula should undergo patch and stability assessment.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; select packaging with the formula's oxidation sensitivity in mind; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Caprylic/Capric Triglyceride centers on light-triglyceride.

• The ingredient record does not support claims of drug action or cure, or a product certification outside the supporting records.
• The ingredient record for Caprylic/Capric Triglyceride cannot verify a whitening effect, acne treatment, perspiration control, sun protection, or hair growth.